JNCCN 360 - Prostate Cancer

Editor:

Sandy Srinivas, MD

Advertisement

Advertisement

Michael J. Morris, MD, on PSMA-Targeted Imaging for Prostate Cancer: CONDOR Trial

Daniel P. Petrylak, MD, on Understanding ARV-110, an Oral PROTAC Degrader for Prostate Cancer Treatment

Neal D. Shore, MD, on a Possible New Standard of Care in Oral Therapy for Advanced Prostate Cancer

Recent

Consensus Conference Offers Guidance on Germline Testing for Prostate Cancer

EUPROMS Study of Quality of Life in Men Treated for Prostate Cancer

Olaparib Monotherapy for Advanced Prostate Cancer With Mutations: TAPUR Update

Darolutamide Plus ADT for Nonmetastatic Prostate Cancer: Final Update From ARAMIS

Published

Medical Literature

African Ancestry–Specific Variant May Be Linked to Familial Prostate Cancer Risk

First-in-Human Phase I Trial of Novel Vaccine in Metastatic Prostate Cancer

Surgery Versus Multimodal Radiotherapy for High-Risk Localized Prostate Cancer

Docetaxel Plus ADT in Minority Patients With Prostate Cancer

Ongoing

Biopsy Combo Boosts Prostate Cancer Detection

Potential for Decision Aids in Prostate Cancer Screening Remain Unknown

Novel Imaging Tools for Prostate Cancer: Facilitating the Management of Patients with Rising PSA and Risk of Recurrence

Proceedings from the First Annual Oncology Nursing Retreat

Available

Clinical Trials

UC San Diego Health Moores Cancer Center

University of Nebraska

Dana-Farber Cancer Institute

NCCN Resources

Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.